Sonic Incytes Medical Corp.

Sonic Incytes Medical Corp. company information, Employees & Contact Information

Sonic Incytes is committed to enhancing patient care through innovative diagnostic solutions. The company's flagship product, Velacur™, equips physicians with an advanced liver imaging tool to help manage the growing epidemic of fatty liver disease. Velacur offers real-time, AI guided quantification of the two key markers for fatty liver disease: liver stiffness and attenuation. With real-time results, a low up-front cost and AI guidance, VELACUR makes liver imaging at the point of care affordable and accessible.

Company Details

Employees
34
Founded
-
Address
1788 W 5th Ave, Suite 309,canada
Email
in****@****tes.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
Keywords
Technician jobs.
HQ
Vancouver, BC
Looking for a particular Sonic Incytes Medical Corp. employee's phone or email?

Sonic Incytes Medical Corp. Questions

News

FDA Grants 510(k) Clearance for Sonic Incytes’ Velacur ONE , AI-Guided Point of Care Ultrasound for the Management of Chronic Liver Diseases - Business Wire

FDA Grants 510(k) Clearance for Sonic Incytes’ Velacur ONE , AI-Guided Point of Care Ultrasound for the Management of Chronic Liver Diseases Business Wire

FDA clears Sonic Incytes’ POCUS device - AuntMinnie

FDA clears Sonic Incytes’ POCUS device AuntMinnie

The Use of Noninvasive Velacur® for Discriminating between Volunteers and Patients with Chronic Liver Disease: A Feasibility Study - Wiley Online Library

The Use of Noninvasive Velacur® for Discriminating between Volunteers and Patients with Chronic Liver Disease: A Feasibility Study Wiley Online Library

FDA grants clearance to Sonic Incytes’ VDFF for liver health assessment - Medical Device Network

FDA grants clearance to Sonic Incytes’ VDFF for liver health assessment Medical Device Network

The Use of Noninvasive Velacur® for Discriminating between Volunteers and Patients with Chronic Liver Disease: A Feasibility Study - Curry - 2024 - International Journal of Hepatology - Wiley Online Library

The Use of Noninvasive Velacur® for Discriminating between Volunteers and Patients with Chronic Liver Disease: A Feasibility Study - Curry - 2024 - International Journal of Hepatology Wiley Online Library

Sonic Incytes raises $3.5 million seed round to commercialize liver health assessment device - BetaKit

Sonic Incytes raises $3.5 million seed round to commercialize liver health assessment device BetaKit

Top Sonic Incytes Medical Corp. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant